Adaptive Biotechnologies Corporation Common Stock (1HM)
Munich
Closed
Oct 9, 2026
Day's Range
23.5552 wk Range
10.96Overview - 1HM - Adaptive Biotechnologies Corporation Common Stock
Key Statistics
Valuation
Enterprise Value
2.95B
P/E (Trailing)
‪-65.74‬
PEG Ratio
‪-1.39‬
Price / Sales (TTM)
‪13.28‬
Price / Book
‪32.68‬
EV / EBITDA
‪-157.84‬
Profitability
Gross Margin
‪71.81%‬
Profit Margin
‪-20.72%‬
Operating Margin
‪-22.04%‬
Return on Assets
‪-4.11%‬
Return on Equity
‪-38.75%‬
Ownership
Shares Outstanding
159.05M
Float
125.48M
Held by Insiders
‪1.29%‬
Held by Institutions
‪99.41%‬
Price stats
Beta
‪2.09‬
50-Day Avg
‪21.52‬
200-Day Avg
‪15.80‬
Dividends
Payout Ratio
‪0.00%‬
Market Cap - 1HM - Adaptive Biotechnologies Corporation Common Stock
Peers - 1HM - Adaptive Biotechnologies Corporation Common Stock
Peer Comparison
Compared with companies in Diagnostics & Research listed on Munich.
Profile Summary - 1HM - Adaptive Biotechnologies Corporation Common Stock
About
Adaptive Biotechnologies Corporation Common Stock represents the equity of Adaptive Biotechnologies Corporation, a commercial-stage biotechnology company focused on immune medicine. The company develops products and services that use immunosequencing, proprietary chemistry, computational biology, and machine learning…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
